Insights

Niche Market Focus Inotek Pharmaceuticals specializes in therapies for serious eye diseases like glaucoma, presenting an opportunity to connect with ophthalmology clinics, eye care centers, and specialized healthcare providers seeking innovative treatments.

Recent Public Offering Having gone public in 2015 with a $40 million raise, Inotek is likely looking to expand its R&D capabilities and commercial reach, making it a potential partner for suppliers of clinical research, lab equipment, and commercialization services.

Growth Potential With an annual revenue between $10 million and $25 million and a small team of up to 50 employees, Inotek offers opportunities for targeted sales in biotech tools, digital health solutions, and specialized pharmaceutical services aimed at scaling a niche biotech firm.

Technology Infrastructure Utilizing standard web technologies like PHP, Apache, and Windows Server, Inotek may be open to partnerships in cybersecurity, cloud services, and IT infrastructure upgrades that support biopharmaceutical research and commercialization.

Strategic Mergers Post-merger with Rocket Pharma in 2018, Inotek likely aims to expand its portfolio and market share in ophthalmic therapies, providing sales opportunities in related healthcare solutions, research collaborations, and therapeutic development services.

Similar companies to Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation Tech Stack

Inotek Pharmaceuticals Corporation uses 8 technology products and services including jQuery CDN, oEmbed, Font Awesome, and more. Explore Inotek Pharmaceuticals Corporation's tech stack below.

jQuery CDN
Content Delivery Network
oEmbed
Dev Tools
Font Awesome
Font Scripts
JSON-LD
Javascript Frameworks
Windows Server
Operating Systems
PHP
Programming Languages
Apache
Web Servers
Nginx
Web Servers

Media & News

Inotek Pharma went public on Aug 15th '15.
Inotek Pharmaceuticals Corporation (the “Company”) today announced the pricing of its initial public offering of 6,667,000 shares of its common stock at a price to the public of $6.00 per share for aggregate proceeds of $40 million, before underwriting discounts.
Aug 14, 2015 | www.inotekpharma.com

Inotek Pharmaceuticals Corporation's Email Address Formats

Inotek Pharmaceuticals Corporation uses at least 1 format(s):

Inotek Pharmaceuticals Corporation Email Formats	Example	Percentage
FLast@inotekpharma.com	JDoe@inotekpharma.com	93%
FirstL@inotekpharma.com	JohnD@inotekpharma.com	4%
FirstLas@inotekpharma.com	JohnDoe@inotekpharma.com	3%

Frequently Asked Questions

Where is Inotek Pharmaceuticals Corporation's headquarters located?

Inotek Pharmaceuticals Corporation's main headquarters is located at 91 Hartwell Avenue 2nd Floor Lexington, Massachusetts 02421 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Inotek Pharmaceuticals Corporation's phone number?

You can contact Inotek Pharmaceuticals Corporation's main corporate office by phone at

+1-781-676-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Inotek Pharmaceuticals Corporation's official website and social media links?

Inotek Pharmaceuticals Corporation's official website is inotekpharma.com and has social profiles on LinkedIn.

What is Inotek Pharmaceuticals Corporation's NAICS code?

Inotek Pharmaceuticals Corporation's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Inotek Pharmaceuticals Corporation have currently?

As of February 2026, Inotek Pharmaceuticals Corporation has approximately 14 employees across 2 continents, including North AmericaAsia. Key team members include President: T. W.Senior Medical Director For Clinical Development And Pharmacovigilance: C. B.Technician: C. C.. Explore Inotek Pharmaceuticals Corporation's employee directory with LeadIQ.

What industry does Inotek Pharmaceuticals Corporation belong to?

Inotek Pharmaceuticals Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does Inotek Pharmaceuticals Corporation use?

Inotek Pharmaceuticals Corporation's tech stack includes jQuery CDNoEmbedFont AwesomeJSON-LDWindows ServerPHPApacheNginx.

What is Inotek Pharmaceuticals Corporation's email format?

Inotek Pharmaceuticals Corporation's email format typically follows the pattern of FLast@inotekpharma.com. Find more Inotek Pharmaceuticals Corporation email formats with LeadIQ.

Inotek Pharmaceuticals Corporation

Q: What technology does Inotek Pharmaceuticals Corporation use?

Inotek Pharmaceuticals Corporation's tech stack includes PHP, Apache, jQuery CDN, Font Awesome, MySQL.

Q: What is Inotek Pharmaceuticals Corporation's NAICS code?

Inotek Pharmaceuticals Corporation's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Inotek Pharmaceuticals was formerly a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The company merged with Rocket Pharma in January 2018.

Company Overview

Headquarters: 91 Hartwell Avenue 2nd Floor Lexington, Massachusetts 02421 United States
Phone number: +1-781-676-****
Website: inotekpharma.com
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Employees: 11-50